←
RaleighLab456 posts
RaleighLab avatar

RaleighLab

@LabRaleigh

Genomic, biochemical, and cellular drivers of brain tumor heterogeneity and evolution. Cancer predisposition syndromes. Response and resistance to treatment.

◷ Joined March 2020▧ 94 Photos and videos
RaleighLab avatar
RaleighLab@LabRaleigh·Apr 9

Wonderful to see this work published, which establishes a new prospective, consecutive benchmark for the population prevalence of molecular alterations in #meningioma. Critical for design of molecularly-guided clinical trials. @UCSFRadOnc @UCSF @UCSFCancer @NeurosurgUCSF

In a new @JAMAOnc study, @LabRaleigh and colleagues report the results from a prospective genomic profiling analysis of more than 1100 meningiomas. Their findings could help guide evolving diagnostic criteria and clinical trial design: jamanetwork.com/journals/jam… @UCSFRadOnc

Post attachment
Aaron Blotnick avatar
⟳ RaleighLab retweeted
Aaron Blotnick@AaronBlotnick·Nov 6

Deep in the recesses of @ucsf, for five years and $67 million, @GSK funded some of the hardest CRISPR experiments ever run. In 2025, Alexander Brown took the helm of the operation and this week, he opened the doors to everyone else as their work with GSK winds down. The Laboratory for Genomics Research was founded in 2019 by Jennifer Doudna with Jonathan Weissman and Hal Barron, a hybrid lab across @UCBerkeley, @UCSF and GSK built for functional genomics at a scale no lab could reach. Alex took over in August 2025. He came from industry, doing some of the hardest to engineer CRISPR programs money could pay for: four and a half years at @Synthego building and maintaining its Cell Engineering Services, then leading development at EditCo Bio when that function spun out. At EditCo he brought the first genome-edited human T cells to market. This week he and his team, Gil Sharon (also ex-Synthego) and Sailaja Peddada, laid out what the LGR will now run for outside groups. SCREENS Genome-scale and targeted. Pooled and arrayed. Knockout, interference and activation. LIBRARIES Custom pooled and arrayed design and construction. Single and dual guide. Plasmid, glycerol or lentiviral. Built for high uniformity and low skew. AUTOMATION BSL-2 automated workcells. High-throughput liquid handling. Automated colony picking. Parallel processing built for scale. READOUTS Single-cell genomics and Perturb-seq. Arrayed high-content imaging. Flow and FACS. Multiparametric phenotyping. DATA SCIENCE Screen analysis and hit prioritization. Bulk and single-cell analysis. Image analysis. Biological interpretation. MODELS Immortalized lines, primary cells, iPSC-derived models and 3D organoids. What that infrastructure produces: Viviana Salinas-Rios is building over a thousand bespoke editors at the Innovative Genomics Institute to find the most precise one for individual patient variants from the clinic. Daniel Fletcher ran a genome-wide screen on cell surface crowding, where crowding costs an antibody 10 to 100 fold in binding affinity, and found no master regulator, just dozens of genes nudging it. Also presenting: James Nuñez, Michael McManus, Roberto Zoncu, Han Yang, Anna Molofsky, Martin Kampmann, Zev Gartner, Alanna Schepartz. @DoudnaJennifer closed the day with @genophoria of @arcinstitute and David Raleigh, with a quote: "(The) kind of data you're all generating is incredibly important. It's high quality data, which we all know doesn't always exist." If you have a screen you cannot run yourself, whether you are in academia, a startup, or a Fortune 500 pharma, they are reachable at: genomicsresearch@ucsf.edu Thanks to @illumina , @thermofisher and @wilsonsonsini for sponsoring such a wonderful event.

Post attachment
Felix Ehret avatar
⟳ RaleighLab retweeted
Felix Ehret@FelixEhretMD·Sep 25

We have waited more than a decade for this: ROAM is presented in Rome #EANO2026! See the results of ROAM/EORTC-1308, now also published in @TheLancet! @EANOassociation thelancet.com/journals/lance…

JAMA Oncology avatar
⟳ RaleighLab retweeted
JAMA Oncology@JAMAOnc·Jul 1

Genomic profiling of consecutive meningiomas found associations between copy number alterations, somatic variants, tumor grade, and patient characteristics, offering insights into prognosis and therapeutic vulnerability. ja.ma/4uVcbiW

Post attachment
RaleighLab avatar
RaleighLab@LabRaleigh·Apr 14

New paper on targeting the #glioblastoma immune microenvironment from an "old" @LabRaleigh postdoc @jakeyoung11, who now has his own lab at @NeurosurgUCSF !! Reach out to him to collaborate or learn more! @UCSFCancer @UCSFRadOnc @UCSF pubmed.ncbi.nlm.nih.gov/4197…